Comprehensive liquid biopsy analysis for monitoring NSCLC patients under second-line osimertinib treatment
Multi-marker analysis of circulating tumor cells in localized intermediate/high-risk and metastatic prostate cancer
Gene expression markers in peripheral blood and outcome in patients with platinum-resistant ovarian cancer: A study of the European GANNET53 consortium
Prognostic significance of circulating tumor cells and tumor related transcripts in small cell lung cancer: A step further to clinical implementation
Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer
Protocol for a prospective study evaluating circulating tumour cells status to predict radical prostatectomy treatment failure in localised prostate cancer patients (C‑ProMeta‑1)
The potential of using circulating tumour cells and their gene expression to predict docetaxel response in metastatic prostate cancer
Effect of short-term storage of blood samples on gene expression in lung cancer patients
A Multi-Center Clinical Study to Harvest and Characterize Circulating Tumor Cells from Patients with Metastatic Breast Cancer Using the Parsortix®PC1 System
Comparison of microfuidic platforms for the enrichment of circulating tumor cells in breast cancer patients